Right on Post-trial Access to Investigational Treatment

The challenge of assuring continued post-trial access to beneficial treatment.

Expanding access to investigational drugs for treatment use: a policy analysis and legislative proposal.

Access to pain treatment as a human right

BACKGROUND Almost five decades ago, governments around the world adopted the 1961 Single Convention on Narcotic Drugs which, in addition to addressing the control of illicit narcotics, obligated countries to work towards universal access to the narcotic drugs necessary to alleviate pain and suffering. Yet, despite the existence of inexpensive and effective pain relief medicines, tens of million...

P-174: Right to Treatment with Assisted Reproductive Technology

Background: Infertility leads to profound human suffering, particularly on the women. Women's lack of pregnancy is both physically and socially visible, especially in high fertility societies where women are typically blamed for reproductive failures, even in cases of male infertility. Childless women are more likely to be the victims of domestic violence and may also endure various forms ...

Forthcoming practical framework for ethics committees and researchers on post-trial access to the trial intervention and healthcare.

When research concludes, post-trial access (PTA) to the trial intervention or standard healthcare can be crucial for participants who are ill such as those in resource-poor countries with inadequate healthcare, British participants testing ‘last-chance drugs’ unavailable on the National Health Service (NHS) and underinsured US participants. Yet, many researchers are unclear about their obligati...